MP Biomedicals announces the launch of advanced gastrointestinal diseases diagnostic kits

FHS
August 27, 2024
11:17 am

MP Biomedicals completes its range of in vitro diagnostic tests for infectious diseases with new immunochromatographic-based qualitative rapid tests.The new diagnostic kits by MP Biomedicals leverage cutting-edge technology to deliver precise results, enabling healthcare professionals a rapid and accurate detection of Helicobacter pylori, Salmonella typhi and Vibrio cholerae serogroups O1 and O139.

Quicktake – BeyondSpring (BYSI) | Biotech Investment Blog | biotickr

BeyondSpring Inc. is an early-stage clinical trial biopharmaceutical company developing immuno-oncology therapies (anti-cancer drugs). The main pipeline is Plinabulin, an anti-cancer drug that is being

June 9, 2023

Childhood vaccination rates, a rare health bright spot in struggling states, are slipping

Jen Fisher can do only so much to keep her son safe from the types of infections that children can encounter at school. The rest,

January 16, 2025

The NASH market holds untapped potential – Pharmaceutical Technology

Source: GlobalData, Deals Database (Accessed: 26 July 2023) © GlobalData. Note: Percentages were calculated from the total number of deals that occurred in 2018–2022. The

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.